scispace - formally typeset
Open AccessJournal ArticleDOI

Prevention Conference VII Obesity, a Worldwide Epidemic Related to Heart Disease and Stroke: Executive Summary

TLDR
On April 27 and 28, 2002, the American Heart Association sponsored a scientific conference, “Obesity, a Worldwide Epidemic related to Heart Disease and Stroke,” in Honolulu, Hawaii, to develop a plan to reduce cardiovascular diseases associated with overweight and obesity.
Abstract
On April 27 and 28, 2002, the American Heart Association (AHA) sponsored a scientific conference, “Obesity, a Worldwide Epidemic Related to Heart Disease and Stroke,” in Honolulu, Hawaii. The purpose of the conference was to develop a plan to reduce cardiovascular diseases (CVDs) associated with overweight and obesity. This report discusses the activities of the 4 working groups held before the conference, presentations at the conference, and extensive discussions among working group members after the conference. The primary objectives of this meeting were to The major findings of each working group are presented in this Executive Summary of the conference proceedings. The complete conference report with references is available online at http://www.circulationaha.org in the November 2, 2004, issue of Circulation . The prevalence of obesity is increasing in virtually all populations and age groups worldwide. Although this increase is most evident in the United States, it is not limited to the more developed, affluent nations of the world. The escalation in obesity rates reflects the upward shift in body weights of individual populations in response to environmental changes. BMI, or weight in kilograms per square meter of height (kg/m2), generally is accepted as a convenient measurement that provides a crude indication of body fat. The classifications of normal weight (BMI 18.5 to 24.9), overweight (BMI 25.0 to 29.9), and obesity (BMI >30.0) are somewhat arbitrary but are based on international analyses of the health impact of different BMIs. By using approaches similar to those used for birth cohort trends in cholesterol …

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

TL;DR: The available evidence of the impact of obesity on CVD is reviewed with emphasis on the evaluation of cardiac structure and function in obese patients and the effect of weight loss on the cardiovascular system.
Journal ArticleDOI

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

TL;DR: CB1 blockade with rimonabant 20 mg, combined with a hypocaloric diet over 1 year, promoted significant decrease of bodyweight and waist circumference, and improvement in cardiovascular risk factors.
Journal ArticleDOI

Ceramides in insulin resistance and lipotoxicity.

TL;DR: The contribution of ceramides in the development of insulin resistance and the complications associated with metabolic diseases is evaluated.
Journal ArticleDOI

Forecasting the Future of Stroke in the United States A Policy Statement From the American Heart Association and American Stroke Association

TL;DR: The projections suggest that the annual costs of stroke will increase substantially over the next 2 decades and greater emphasis on implementing effective preventive, acute care, and rehabilitative services will have both medical and societal benefits.
Related Papers (5)